Investor Information


Injectsense received Series B funding in April 2019 for development and testing of its sensor enabled digital health system. It is currently engaged in raising funds for Series C. The company also generates revenue from projects with healthcare strategics and solution partners. 


To learn more about the company and investment opportunities, please contact


CAUTION - Investigational Device. Limited by Federal law to investigational use.



Corporate Headquarters


Injectsense, Inc.
2000 Powell St

Suite 1425 
Emeryville, CA 94608


(510) 292-4120



Twin Cities


Injectsense, Inc.

7825 Washington Ave. South

Suite 650

Minneapolis, MN 55439





  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Facebook Social Icon